Island Pharmaceuticals Secures R&D Tax Refund Boost

Island Pharmaceuticals Ltd (AU:ILA) has released an update.

Island Pharmaceuticals has received an $865,230 refund under Australia’s R&D Tax Incentive, which has allowed them to repay a loan from Radium Capital. This funding comes as the company advances its clinical programs, including the promising ISLA-101 nearing a Phase 2a data readout, and explores new assets like galidesivir.

For further insights into AU:ILA stock, check out TipRanks’ Stock Analysis page.